Chicharros USA - bolsa internacional

Para cómo han esta las cosas hasta hace nada, veo bastante verde...

Buenas tardes a todos,

KAVL

De nuevo están pitando mucho, Sniper... La noticia que salió en su día, motivo de todo esto, es importante... porque como se ponga a recuperar todo lo perdido desde septiembre de 2021... tiene todavía mucho por dar... En 0.80 estuve tentado de entrar... de lo poquito que me ha interesado en las últimas semanas... Estoy muy pasivo...

 Kaival Brands Innovations shares are trading higher after the company announced the U.S. Court of Appeals for the Eleventh Circuit has granted a judicial stay of the marketing denial order previously issued by the FDA to Bidi Vapor in September 2021. 

RELI
Que buen juego están dando estas bichas ...

BRQS

Calatas... Yo no las llevo..pero te adjunto la información que tengo de ellas... El plazo, en teoría, se cumple la semana que viene... Tienen hasta el 14 de Febrero, es decir, hasta el próximo lunes... Podrían ampliarle el plazo, pero a saber... Una lotería...

Y sobre las NVIV... lo que alcanzo a leer es que el plazo ya expiró el 15 de noviembre.. con lo cual supongo que debieron recibir una prórroga, pero tampoco he conseguido leer ninguna noticia que lo confirmara..

Suerte...!!!

 

SANTA CLARA, Calif., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), today announced that the Company has received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 18, 2021, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq’s rules for continued listing on the Nasdaq. 

Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's ordinary shares for the 30 consecutive business days from July 7, 2021 to August 17, 2021, the Company no longer meets the minimum bid price requirement. 

The Notification Letter does not impact the Company's listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until February 14, 2022, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company's ordinary shares must have a closing bid price of at least US$1.00 for a minimum of 10 consecutive trading days. In the event the Company does not regain compliance by February 14, 2022, the Company may be eligible for additional time to regain compliance or may face delisting. If during any compliance period the ordinary shares have a closing bid price of $0.10 or less for 10 consecutive trading days, Nasdaq’s Listing Qualifications Department shall issue a Staff Delisting Determination.


 

On May 19, 2021, InVivo Therapeutics Holdings Corp. (the "Company") received a deficiency letter from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying the Company that, for the previous 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Requirement").

Muchas gracias Templarivm

XELA
A esta le van a dar ya un toque para el delisting porque lleva ya casi un mes por debajo del dólar .... como no reaccione rápido las largo.
En 0,698 tiene un soporte , lo ha tocado y ha rebotado un poco, si se mantiene por encima de ese valor  mejor , si se va para abajo mal vamos. Resistencia en 0,72 , si la supera iremos mejorando , y etc , etc , etc

Dentro SREV a 1,1

Dentro TXMD dentro 0,2614